Intracardiac echocardiography recognized as ‘transformative’ imaging modality in new SCAI position statement

Published in JSCAI, the statement outlines how ICE can improve safety, efficiency, and patient access across structural heart interventions.

2025-10-07

(Press-News.org) WASHINGTON—The Society for Cardiovascular Angiography & Interventions (SCAI) has published a comprehensive roadmap that details the use of intracardiac echocardiography (ICE) to guide structural heart disease (SHD) interventions for clinicians. ICE represents a significant departure from the traditional reliance on transesophageal echocardiography (TEE) by providing clinicians with real-time, high-resolution imaging from inside the heart without the need for general anesthesia.

Published in JSCAI, “SCAI Position Statement on Intracardiac Echocardiography to Guide Structural Heart Disease Interventions” examines the advantages, limitations, and best practices for ICE, which is increasingly being integrated into procedures such as mitral, tricuspid, and pulmonary valve interventions, as well as left atrial appendage closure (LAAC), atrial septal defect (ASD), and patent foramen ovale (PFO) closure.

“This technology is revolutionizing the way transcatheter procedures are performed. ICE has matured from a niche tool into a frontline technology for guiding structural interventions,” said Mackram F. Eleid, MD, FSCAI, Chair of the writing group and interventional cardiologist at Mayo Clinic. “This is not just about better imaging. It is about better outcomes. ICE allows us to avoid general anesthesia, reduce complications, and, in many cases, discharge patients the same day. For patients, this means a safer and less invasive experience. For clinicians, it means more precision and confidence during complex procedures. The statement reflects an international consensus that ICE is ready to be widely adopted.”

The document provides standardized ICE imaging protocols and views tailored to specific interventions, offering operators a structured approach to integrating ICE into their practice. It emphasizes training pathways for physicians, the need for workflow redesign within cath labs, and institutional readiness to ensure safe and effective implementation.

“ICE is more than an alternative to TEE. It is changing how we think about structural heart care,” said Omar K. Khalique, MD, FSCAI, Co-Chair of the writing group and Director of Cardiovascular Imaging at St. Francis Hospital & Heart Center. “By eliminating the need for general anesthesia in many cases, ICE makes procedures possible for patients who might otherwise be turned away due to frailty or comorbidities. It also streamlines scheduling, reduces the burden on anesthesia teams, and improves efficiency in the cath lab. With advancing technology and the right training, ICE has the potential to become the default imaging modality for some structural interventions in the years ahead.”

Beyond protocols and workflows, the statement highlights ongoing barriers to adoption, particularly those related to reimbursement, as current coding does not fully account for the complexity of ICE-guided procedures or the role of interventional imaging specialists. The writing group urged policymakers to update reimbursement models so that hospitals and physicians are appropriately supported in offering ICE. The position statement also called for further comparative studies of ICE and TEE, particularly in mitral and tricuspid interventions, where evidence is still emerging.

About SCAI
The Society for Cardiovascular Angiography and Interventions is a professional organization representing more than 5,000 invasive and interventional cardiology professionals in approximately 75 nations. SCAI's mission is to promote excellence in invasive/interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. www.scai.org

END

ELSE PRESS RELEASES FROM THIS DATE:

Study finds ‘man’s best friend’ slows cellular aging in female veterans

2025-10-07

New research finds that “man’s best friend” may help slow biological aging in women. This groundbreaking study, focused on female veterans in the United States, is among the first to examine the impact of working with service dogs on this often-overlooked population. By measuring biological indicators of stress, the researchers have uncovered a key insight: the way stress is felt emotionally doesn’t always reflect how it affects the body at a cellular level. While women have served in the U.S. military for generations, ...

To get representative health data, researchers hand out fitbits

2025-10-07

A study finds that a representative sample of people given wearable data collection devices provides more equitable and accurate health data than larger convenience samples of people who already own wearable devices. Leveraging the smartwatches and other data-logging wearables that people already have is a tempting way to gather data, but such groups overrepresent the wealthy, urban, White, and fit people who tend to buy these products. Ritika Chaturvedi and colleagues recruited 1,038 participants for American Life in Realtime (ALiR), a longitudinal health study that provided Fitbits ...

Hiring in high-growth firms: new study explores the timing of organizational changes

2025-10-07

High-growth firms (HGFs) refer to businesses that achieve rapid growth in terms of employees or revenue. Based on the established definition, HGFs are businesses with at least 10 employees and annual growth rates of 20% or more, observed over a period of three years. This three-year span is considered the high-growth (HG) period of the company. Even though this growth is often short-lived and difficult to sustain, it plays a significant role in driving economic dynamism. Hence, entrepreneurship-related research often focuses on the growth ...

Boosting work engagement through a simple smartphone diary

2025-10-07

Work engagement is a positive and persistent state of mind related to one’s work. It is characterized by high energy and mental resilience (vigor), enthusiasm and involvement (dedication), and complete concentration in the task at hand (absorption). Engaged workers are not merely more productive; they are more likely to be proactive, creative, and less susceptible to burnout. Most importantly, work engagement has been consistently linked to many health benefits and overall well-being. Despite its relevance for both organizations and workers alike, there aren’t many scientifically proven ...

Climate change may create ‘ecological trap’ for species who can’t adapt

2025-10-07

CLEVELAND—Even as autumn days grow shorter, a warming climate means Ohio winters aren't as cold as they were just a few decades ago, according to National Oceanic and Atmospheric Administration data. This increasing mismatch between hours of daylight and temperature could spell trouble for animals that thrive by relying on seasonal cues to prepare their bodies for winter, according to new research from Case Western Reserve University. Scientists studying gray tree frogs—a species that survives freezing temperatures by storing “antifreeze” compounds in their bodies—have discovered that these amphibians naturally begin to prepare for winter by responding ...

Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date

2025-10-07

Seattle, WASH.—October 7, 2025—In a powerful fusion of AI and neuroscience, researchers at the University of California, San Francisco (UCSF) and Allen Institute designed an AI model that has created one of the most detailed maps of the mouse brain to date, featuring 1,300 regions/subregions. This new map includes previously uncharted subregions of the brain, opening new avenues for neuroscience exploration. The findings were published today in Nature Communications. They offer an unprecedented level of detail and advance our understanding of the brain by allowing researchers ...

AI and omics unlock personalized drugs and RNA therapies for heart disease

2025-10-07

AI and omics unlock personalized drugs and RNA therapies for heart disease AI, omics, and systems biology can now help scientists design targeted drugs for cardiovascular disease pathways once thought “untreatable.” A new article published in Frontiers in Science says these tools could transform heart drug development and save lives—but that global, equitable health policy leadership is urgently needed. Despite major advances in cardiovascular care, heart disease remains the world’s leading cause of death. This is partly because cardiovascular medicine still largely relies on broad-brush ...

2023 ocean heatwave ‘unprecedented but not unexpected’

2025-10-07

The June 2023 heatwave in northern European seas was “unprecedented but not unexpected”, new research shows. During the heatwave, temperatures in the shallow seas around the UK (including the North Sea and Celtic Sea) reached 2.9°C above the June average for 16 days. While unprecedented since observations began, the study warns that rapid climate change means there is now about a 10% chance of a marine heatwave of this scale occurring each year. The June 2023 marine heatwave significantly disrupted phytoplankton blooms. Although its full impact ...

Johns Hopkins researchers develop AI to predict risk of US car crashes

2025-10-07

In a significant step towards improving road safety, Johns Hopkins University researchers have developed an A.I.-based based tool that can identify the risk factors contributing to car crashes across the United States and to accurately predict future incidents. The tool, called SafeTraffic Copilot, aims to provide experts with both crash analyses and crash predictions to reduce the rising number of fatalities and injuries that happen on U.S. roads each year. The work, led by Johns Hopkins ...

New drug combination offers hope for men with advanced prostate cancer

2025-10-07

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL researchers. The Phase III AMPLITUDE trial, published in Nature Medicine, tested the addition of niraparib, a type of targeted cancer drug known as a PARP inhibitor1, to the standard treatment of abiraterone acetate and prednisone (AAP).2 The study focused on patients diagnosed with advanced prostate cancer where cells have spread to other parts of the body, who were starting their first ...

LAST 30 PRESS RELEASES:

Engineers develop solid lubricant to replace toxic materials in farming

Repurposing gemstone polishing waste to create smart cement

Patient-physician messaging by race, ethnicity, insurance type, and preferred language

Unrecognized motor difficulties and developmental coordination disorder in preschool children

Background genetic variants influence clinical features in complex disorders

Smarter battery tech knows whether your EV will make it home

Overactive microRNAs block fat cell development in progeria

Crosswalk confusion: MA drivers flummoxed by pedestrian hybrid beacons, find UMass Amherst researchers

Study shows heart disease mortality disproportionately burdens low-income communities in California